You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. sHLA Protein Chip

    SBC: GENOMICS USA, INC.            Topic: NIAID

    Abstract: “sHLA Protein Chip” The class I [A, B, C] and class II HLA proteins [DRB1, DQ, DP] comprise the heart of the inducible human immune system. For organ, marrow and stem cell transplantation, the development of serum-born antibodies against one or more of those many HLA proteins comprises the best and earliest test for transplant rejection. Because of the enormous medical importance of ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  2. Indoor Navigation Aid for Individuals with Visual Impairments in Unfamiliar Spaces

    SBC: VORTANT TECHNOLOGIES LLC            Topic: na

    This project develops a technology solution to address the indoor navigation needs experienced by people with visual disabilities. This technology has several advantages over other wayfinding approaches such as GPS, in that it requires no infrastructure in indoor spaces nor does it require maps to be created prior to navigation. Thus, it is applicable to any unfamiliar indoor or outdoor space. The ...

    SBIR Phase II 2018 Department of Health and Human ServicesAdministration for Community Living
  3. Developmentally Appropriate Technology for Science Assessment in Early Elementary Grades

    SBC: 3-C Institute for Social Development, Inc.            Topic: 99190018R0006

    In this project, researchers will develop a prototype of Science Quest, a tool to assess the science skills and understanding for students in grades 1 to 3. The prototype will deliver psychometrically validated assessment items in a game-like format. Educators will be able to assign and monitor completion of science assessments, view assessment results in real-time with reports at the individual a ...

    SBIR Phase I 2018 Department of EducationInstitute of Education Sciences
  4. Development of Taenia Solium Specific Aptamers for Diagnostic Assays

    SBC: LYNNTECH INC.            Topic: ODCDC

    The parasitic tapeworm Taenia solium causes two diseasestaeniasisadult worm in the intestineand cysticercosistissue infection by the cystwhich can lead to seizuresThe Tsolium life cycle involves both humans and pigshowever humans are the only definitive host for the adult Tsolium tapewormDiagnosing people infected with the adult worm is a critical step toward eliminating Tsolium althogetherHowever ...

    SBIR Phase I 2018 Department of Health and Human ServicesCenters for Disease Control and Prevention
  5. Web Based Application to Promote Workplace Health Through Behavioral Design

    SBC: Innovation Research And Training, Inc.            Topic: ODCDC

    Healthy design features in a workplace can enable healthy eating and physical activitywhich are key behaviors in the prevention of obesity and other chronic diseasesAs of yetthere is no comprehensive webbased tool for designers and employers in different types of workplacesparticularly small business settingsto learn about and implement behavioral design strategies in the workplaceThe goal of this ...

    SBIR Phase I 2018 Department of Health and Human ServicesCenters for Disease Control and Prevention
  6. Topic 346: Targeted Radionuclide Therapy of Neuroendocrine Tumors Using 212Pb-octreotate Analogs

    SBC: RADIOMEDIX, INC.            Topic: NCI

    A peptide receptor radionuclide therapy (PRRT) using [177Lu]/[90Y]-labeled somatostatin analogs has been proven to induce objective response in 30-45% of patients with advanced/progressive neuroendocrine tumors (NETs). The complete response to beta-emitter PRRT is rare. This is due to the fact that NETs are diagnosed at late stage of disease; the NETs patients with remissions could develop resista ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  7. Topic 377: Enabling Clinical Decision Support for Guideline Based Cancer Symptom Management

    SBC: KLESIS, LLC            Topic: NCI

    The objective of this proposal is to develop an electronic, rule-based clinical decision support system (CDS-Sx) that leverages national clinical practice guidelines (CPGs) to improve cancer symptom management. Specific tasks that will be performed include: 1) create software-ready computable algorithms for managing cancer-related fatigue and constipation that have been vetted with diverse cancer ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. Topic 379: Extensible and Scalable Platform for Data Integration from Wearable Sensors to Generate Novel Analytics for Cancer Patients

    SBC: Litmus Health, Inc.            Topic: NCI

    The longterm objective of the Litmus Health platform is to allow researchers and clinicians to use data on cancer patients from wearables/sensors and smartphones. Collecting real-time, high-quality data from patients will transform care and clinical trials. Automating data collection, storage, analysis, and interpretation of data will result in better measurement of signs and symptoms and improved ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Topic 372: Highly multiplexed selection of aptamers to hundreds of canine immunotherapy targets

    SBC: BASE PAIR BIOTECHNOLOGIES INC            Topic: NCI

    The preclinical development of cancer therapeutics, including the recent trend and focus on cancer immunotherapies, is evolving from the traditional use of mouse models to the use of other animal models including canine, rat, and minipig. Each of these non-mouse models carries its own advantages and abilities to increase the clinical relevance of the model as compared to mouse models. Yet, the wid ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  10. In situ assay for RNA decapping in tumors

    SBC: VIVID TECHNOLOGIES INC            Topic: 102

    In situ assay for RNA decapping in tumors Abstract This project aims to introduce a new histotechnology to assess tumor cell stress and cell death propensitywhich can be useful in evaluating cancer response to therapyThe adaptive response of tumor cells to stress and their survival in hostile environments are signaled by the levels of mRNA decayIncreased decay dumps important mRNAs and marks cells ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government